Pharmaceuticals and Medical Devices Agency Japan

E555156

The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.

Try in SPARQL Jump to: Surface forms Statements Referenced by

Observed surface forms (2)

Statements (49)

Predicate Object
instanceOf government agency
independent administrative institution
regulatory agency
abbreviation PMDA NERFINISHED
alsoKnownAs PMDA Japan NERFINISHED
cooperatesWith European Medicines Agency NERFINISHED
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NERFINISHED
Ministry of Health, Labour and Welfare NERFINISHED
U.S. Food and Drug Administration NERFINISHED
World Health Organization NERFINISHED
country Japan
hasOfficialWebsite https://www.pmda.go.jp
headquartersLocation Chiyoda, Tokyo, Japan NERFINISHED
Tokyo, Japan NERFINISHED
jurisdiction Government of Japan
languageOfWorkOrName Japanese
legalForm independent administrative institution of Japan
mandate ensure quality, efficacy, and safety of medical devices in Japan
ensure quality, efficacy, and safety of pharmaceuticals in Japan
nativeName 医薬品医療機器総合機構 NERFINISHED
parentOrganization Ministry of Health, Labour and Welfare NERFINISHED
performs benefit-risk assessment of medical products
regulatory science research
risk management of medical products
regionServed Japan
regulates biopharmaceuticals
in vitro diagnostic medical devices
over-the-counter drugs
prescription drugs
responsibleFor GCP inspections
GLP inspections
GMP inspections
adverse drug reaction assessment
adverse event reporting system
drug safety monitoring
medical device regulation
medical device safety monitoring
pharmaceutical regulation
pharmacovigilance
post-marketing surveillance
regulation of cellular and gene therapy products
regulation of regenerative medical products
review of clinical trial notifications
review of generic drug applications
review of medical device applications
review of new drug applications
sector healthcare regulation
medical device regulation
pharmaceutical regulation

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

ICH Q9 Quality Risk Management regionallyImplementedBy Pharmaceuticals and Medical Devices Agency Japan
ICH M4 Common Technical Document adoptedBy Pharmaceuticals and Medical Devices Agency Japan
this entity surface form: Pharmaceuticals and Medical Devices Agency of Japan